NSE · SAIPARENT
Sai Parenterals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,140
of 5,004 stocks
🏆 New peak
▲ 291W
Peak #1,140 · 01 Oct 2026
Sai Parenterals Limited, a smallcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is seeing revenue contract sharply, and has a subdued return on equity.
Market Cap
2,338.45 Cr
P/E Ratio
121.40
P/B Ratio
4.72
ROE
2.88%
ROCE
3.57%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 178.67 Cr | 197.93 Cr | 96.15 Cr | 269.12 Cr |
| Net Profit | 7.92 Cr | 13.16 Cr | -6.66 Cr | -1.18 Cr |
| EPS | 1.79 | 4.02 | 2.22 | — |
| Operating Profit | 19.15 Cr | 20.79 Cr | -6.22 Cr | 14.32 Cr |
Shareholding pattern
Promoter
51.16%
Public
48.84%
Mutual fund holdings
₹0.56
Cr total
1
Schemes
1
Fund Houses
₹0.56 Cr
Total Exposure
Bandhan Mutual Fund₹0.56 Cr (100.0%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.